In the Azurion system, the user can add a new study to a patient by selecting the option Add
Study . The Add Study dialogue box is then displayed where the Patient Type is selected to
perform the study. Due to a software defect, when the study is initiated by pressing Start
Procedure , the Patient Type changes inadvertently to a Patient Type different than the one
selected as shown in the Table below. Patient type is one of the factors involved in the dose
control process. The incorrect patient type changes the technique factors to be used by the
system without notification to the user.
Source facts
Action
Philips notified customers of the issue via Electronic Product Radiation Defect notification letter dated March 4, 2022. The letter identified the affected product, problem and actions to be taken. Customers were informed that they will be contacted by a Philips Field Service Engineers to schedule the software update at no cost. For questions contact your local Philips representative: 1-800-722-9377.
Initiated
2021-05-26
Root cause
Software design
Distribution
US Nationwide and Worldwide Distribution
Recall number
Z-0886-2022
Recall status
Open, Classified
CDRH record ID
192996
FDA classified
2022-05-03
Recall event number
89964
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.